vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and XPLR Infrastructure, LP (XIFR). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($346.4M vs $249.0M, roughly 1.4× XPLR Infrastructure, LP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 11.2%, a 16.8% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs -15.3%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $-88.0M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (1.5% CAGR vs -1.6%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
XPLR Infrastructure is a publicly traded subsidiary of NextEra Energy, is a Juno Beach, Florida-based renewable energy company.
HAE vs XIFR — Head-to-Head
Income Statement — Q4 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $346.4M | $249.0M |
| Net Profit | $97.3M | $28.0M |
| Gross Margin | 57.2% | — |
| Operating Margin | 36.1% | -19.3% |
| Net Margin | 28.1% | 11.2% |
| Revenue YoY | 4.8% | -15.3% |
| Net Profit YoY | — | 124.3% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $346.4M | — | ||
| Q4 25 | $339.0M | $249.0M | ||
| Q3 25 | $327.3M | $315.0M | ||
| Q2 25 | $321.4M | $342.0M | ||
| Q1 25 | $330.6M | $282.0M | ||
| Q4 24 | $348.5M | $294.0M | ||
| Q3 24 | $345.5M | $319.0M | ||
| Q2 24 | $336.2M | $360.0M |
| Q1 26 | $97.3M | — | ||
| Q4 25 | $44.7M | $28.0M | ||
| Q3 25 | $38.7M | $-37.0M | ||
| Q2 25 | $34.0M | $79.0M | ||
| Q1 25 | $58.0M | $-98.0M | ||
| Q4 24 | $37.5M | $-115.0M | ||
| Q3 24 | $33.8M | $-40.0M | ||
| Q2 24 | $38.4M | $62.0M |
| Q1 26 | 57.2% | — | ||
| Q4 25 | 59.7% | — | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.5% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | — |
| Q1 26 | 36.1% | — | ||
| Q4 25 | 19.9% | -19.3% | ||
| Q3 25 | 17.9% | 1.6% | ||
| Q2 25 | 16.8% | 26.3% | ||
| Q1 25 | 21.6% | -82.6% | ||
| Q4 24 | 16.9% | -188.1% | ||
| Q3 24 | 15.0% | 15.4% | ||
| Q2 24 | 11.8% | 18.3% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 13.2% | 11.2% | ||
| Q3 25 | 11.8% | -11.7% | ||
| Q2 25 | 10.6% | 23.1% | ||
| Q1 25 | 17.5% | -34.8% | ||
| Q4 24 | 10.8% | -39.1% | ||
| Q3 24 | 9.8% | -12.5% | ||
| Q2 24 | 11.4% | 17.2% |
| Q1 26 | — | — | ||
| Q4 25 | $0.95 | — | ||
| Q3 25 | $0.81 | $-0.40 | ||
| Q2 25 | $0.70 | $0.84 | ||
| Q1 25 | $1.17 | $-1.05 | ||
| Q4 24 | $0.74 | — | ||
| Q3 24 | $0.66 | $-0.43 | ||
| Q2 24 | $0.74 | $0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.4M | $960.0M |
| Total DebtLower is stronger | $1.2B | $6.2B |
| Stockholders' EquityBook value | $796.3M | $10.9B |
| Total Assets | $2.4B | $19.6B |
| Debt / EquityLower = less leverage | 1.53× | 0.57× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.4M | — | ||
| Q4 25 | $363.4M | $960.0M | ||
| Q3 25 | $296.4M | $711.0M | ||
| Q2 25 | $292.9M | $880.0M | ||
| Q1 25 | $306.8M | $1.5B | ||
| Q4 24 | $320.8M | $283.0M | ||
| Q3 24 | $299.3M | $290.0M | ||
| Q2 24 | $344.4M | $281.0M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $6.2B | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | $5.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $796.3M | — | ||
| Q4 25 | $911.5M | $10.9B | ||
| Q3 25 | $849.2M | $11.0B | ||
| Q2 25 | $882.3M | $11.3B | ||
| Q1 25 | $820.8M | $12.6B | ||
| Q4 24 | $906.9M | $12.9B | ||
| Q3 24 | $878.9M | $13.6B | ||
| Q2 24 | $905.4M | $13.9B |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $19.6B | ||
| Q3 25 | $2.4B | $19.1B | ||
| Q2 25 | $2.5B | $20.5B | ||
| Q1 25 | $2.5B | $21.4B | ||
| Q4 24 | $2.5B | $20.3B | ||
| Q3 24 | $2.5B | $20.9B | ||
| Q2 24 | $2.5B | $21.7B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.34× | 0.57× | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | 0.41× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $293.2M | $186.0M |
| Free Cash FlowOCF − Capex | $209.9M | $-88.0M |
| FCF MarginFCF / Revenue | 60.6% | -35.3% |
| Capex IntensityCapex / Revenue | 9.5% | 110.0% |
| Cash ConversionOCF / Net Profit | 3.01× | 6.64× |
| TTM Free Cash FlowTrailing 4 quarters | $417.1M | $-219.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $293.2M | — | ||
| Q4 25 | $93.6M | $186.0M | ||
| Q3 25 | $111.3M | $231.0M | ||
| Q2 25 | $17.4M | $232.0M | ||
| Q1 25 | $116.6M | $90.0M | ||
| Q4 24 | $43.8M | $283.0M | ||
| Q3 24 | $48.8M | $208.0M | ||
| Q2 24 | $-27.4M | $231.0M |
| Q1 26 | $209.9M | — | ||
| Q4 25 | $87.2M | $-88.0M | ||
| Q3 25 | $106.3M | $-283.0M | ||
| Q2 25 | $13.6M | $151.0M | ||
| Q1 25 | $100.9M | $1.0M | ||
| Q4 24 | $35.2M | $231.0M | ||
| Q3 24 | $39.4M | $152.0M | ||
| Q2 24 | $-33.1M | $162.0M |
| Q1 26 | 60.6% | — | ||
| Q4 25 | 25.7% | -35.3% | ||
| Q3 25 | 32.5% | -89.8% | ||
| Q2 25 | 4.2% | 44.2% | ||
| Q1 25 | 30.5% | 0.4% | ||
| Q4 24 | 10.1% | 78.6% | ||
| Q3 24 | 11.4% | 47.6% | ||
| Q2 24 | -9.8% | 45.0% |
| Q1 26 | 9.5% | — | ||
| Q4 25 | 1.9% | 110.0% | ||
| Q3 25 | 1.5% | 163.2% | ||
| Q2 25 | 1.2% | 23.7% | ||
| Q1 25 | 4.7% | 31.6% | ||
| Q4 24 | 2.5% | 17.7% | ||
| Q3 24 | 2.7% | 17.6% | ||
| Q2 24 | 1.7% | 19.2% |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.09× | 6.64× | ||
| Q3 25 | 2.88× | — | ||
| Q2 25 | 0.51× | 2.94× | ||
| Q1 25 | 2.01× | — | ||
| Q4 24 | 1.17× | — | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | -0.71× | 3.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
XIFR
| Renewable Energy Sales | $238.0M | 96% |
| Related Party | $8.0M | 3% |
